Importance of Multidisciplinary Approach in Care of CAR-T MM Patients

Opinion
Video

This segment explores Dr. Rossi's clinical experience with cilta-cel as a second-line therapy, focusing on its efficacy and quality-of-life benefits across diverse patient populations.

Video content above is prompted by the following:

  • Can you share your experience with cilta-cel as a second-line therapy?
  • What advantages in terms of efficacy and quality of life have you noted across various patient populations?

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
1 expert in this video
1 expert in this video
1 expert in this video
Related Content